98.00
98.00
Inclusive of all taxes
You Save: 0. Discount 0%
Product is not available
CARDINOL PLUS Tablet is a fixed-dose combination of Metoprolol Succinate and Hydrochlorothiazide, primarily prescribed for the effective management of hypertension (high blood pressure) and related cardiovascular conditions. By combining a cardioselective beta-blocker and a thiazide diuretic, CARDINOL PLUS offers dual-action blood pressure control, reduction of cardiovascular risk, and organ protection. Manufactured under international quality standards by BluepillExpress, this formulation provides enhanced therapeutic efficacy, excellent patient compliance, and consistent safety across diverse patient populations.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
CARDINOL PLUS Tablet is a pharmacologically advanced combination therapy designed to control elevated blood pressure and reduce the risk of cardiovascular morbidity and mortality. It contains Metoprolol Succinate, a selective beta-1 adrenergic receptor blocker, and Hydrochlorothiazide, a thiazide diuretic, in an optimized fixed dose that offers both heart rate control and volume reduction. Together, these agents address two different mechanisms of blood pressure elevation—cardiac output and fluid overload—leading to superior antihypertensive efficacy compared to monotherapy.
Metoprolol Succinate, the primary component of CARDINOL PLUS, is a beta-1 selective beta-blocker known for its efficacy in reducing heart rate, cardiac workload, and blood pressure. It works by blocking the beta-1 receptors in the heart, leading to a decrease in heart rate and myocardial contractility. This results in reduced oxygen demand, making Metoprolol particularly beneficial in hypertensive patients with angina, arrhythmias, or post-myocardial infarction status. Its once-daily extended-release formulation ensures consistent 24-hour blood pressure control, minimizing peak-trough fluctuations and enhancing patient compliance.
Hydrochlorothiazide complements Metoprolol by promoting renal excretion of sodium and water, thereby reducing intravascular volume and decreasing peripheral resistance. As a thiazide diuretic, it is especially effective in salt-sensitive hypertensive patients and contributes to long-term blood pressure regulation. Moreover, Hydrochlorothiazide has been shown to reduce the risk of stroke and congestive heart failure in hypertensive individuals, making it a valuable addition to this combination therapy.
CARDINOL PLUS Tablet is indicated for patients who require combination therapy for hypertension, especially those not adequately controlled with beta-blocker monotherapy. It is particularly useful in patients with coexisting heart failure, ischemic heart disease, or left ventricular hypertrophy. The dual action ensures a comprehensive approach to cardiovascular protection, reducing the chances of complications such as stroke, myocardial infarction, renal failure, and aortic dissection.
